Finance

Lists
Why is KYTX up ३.४०%?
Dive Deeper
KYTX:NASDAQ
Kyverna Therapeutics Inc
US$ ६.३९
+३.४०%
(+०.२१) 1D
US$ ६.३९
०.००% (०.००)
After hours
Closed: अक्टोबर ९, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYTX...
Open
US$ ६.२०
High
US$ ६.५८
Low
US$ ६.१८
Mkt. cap
३९.५२ करोड
Avg. vol.
९.०७ लाख
Volume
८.७६ लाख
52-wk high
US$ १३.६७
52-wk low
US$ ५.९६
EPS
-US$ २.९४
Shares outstanding
६.१८ करोड
No. of employees
१४९
Open
US$ ६.२०
High
US$ ६.५८
Low
US$ ६.१८
Mkt. cap
३९.५२ करोड
Avg. vol.
९.०७ लाख
Volume
८.७६ लाख
52-wk high
US$ १३.६७
52-wk low
US$ ५.९६
EPS
-US$ २.९४
Shares outstanding
६.१८ करोड
No. of employees
१४९
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
२४ मिनेट पहिले
What AppLovin Bears Saw Before A 51% Drop
Yahoo Finance
Yahoo Finance
·
४ घण्टा पहिले
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
24/7 Wall St.
24/7 Wall St.
·
१८ घण्टा पहिले
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Seeking Alpha
Seeking Alpha
·
१२ घण्टा पहिले
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
About Kyverna Therapeutics Inc
CEO-
Employees१४९
Founded२०१८
HeadquartersEmeryville, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitekyvernatx.com
Analyst ratings
Based on 4 analysts giving stock ratings to KYTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KYTX in the last 3 months.
Highest
Current US$ ६.३९
US$ ३३.०० (+४१६.४३%)
Average
US$ ३०.३३ (+३७४.६५%)
Lowest
US$ २५.०० (+२९१.२४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$ २५.००
+२९१.२%
09/25/2026
Derek Archila
Wells Fargo
Buy
Reiterated
US$ ३३.००
+४१६.४%
09/25/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
09/24/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
US$ ३३.००
+४१६.४%
08/12/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/12/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
US$ २९.००
+३५३.८%
05/13/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
US$ ३०.००
+३६९.५%
03/30/2026
Last report
२०२६ अगस्ट ११
Fiscal period
Q2 2026
-US$ ०.६३ / -US$ ०.६८
+७.२८%beat
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
३.०५ करोड
-१०.३७ करोड
३.०१ करोड
-
Cost of revenue
३.०५ करोड
-१०.३७ करोड
३.०१ करोड
-
Research and development expenses
-
१३.३७ करोड
-
२.४८ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८२.७० लाख
९२.६८ लाख
१.१३ करोड
१.४८ करोड
Operating expense
८२.७० लाख
१४.३० करोड
१.१३ करोड
३.९६ करोड
Total operating expenses
३.८७ करोड
३.९३ करोड
४.१४ करोड
३.९६ करोड
Operating income
-३.८७ करोड
-३.९३ करोड
-४.१४ करोड
-३.९६ करोड
Other non operating income
-५३.०० हजार
१७.०० हजार
-२१.०० हजार
-१८.०० हजार
EBT including unusual items
-३.६८ करोड
-३.७८ करोड
-३.९७ करोड
-३.८३ करोड
EBT excluding unusual items
-३.६८ करोड
-३.७८ करोड
-३.९७ करोड
-३.८३ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३.६८ करोड
-३.७८ करोड
-३.९७ करोड
-३.८३ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.८५
-०.८०
-०.६६
-०.६३
Interest and investment income
२०.०० लाख
१९.०५ लाख
२३.२७ लाख
१९.२९ लाख
Interest expense
-७.०० हजार
-४.४४ लाख
-६.६७ लाख
-६.७४ लाख
Net interest expenses
१९.९३ लाख
१४.६१ लाख
१६.६० लाख
१२.५५ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.७८ करोड
-३.८९ करोड
-४.१० करोड
-३.९१ करोड
Gain or loss from assets sale
४०.०० हजार
२०.०० हजार
-
-४७.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू